Skip to main content

Table 2 Summary of 12 patients with postoperative intrahepatic bile duct stones

From: Current treatment strategies for postoperative intrahepatic bile duct stones in congenital biliary dilatation: a single center retrospective study

No.

Age at surgery for CBD

Sex

Todani

Site of stenosis

Age at diagnosis of IHBD stone

Symptom due to IHBD stone

Treatment for IHBD stone

Outcome

1

1 month

F

Ia

posterior segmental branch

28 years

recurrent cholangitis abdominal pain

DB-ERC - > PTCD

no change

2

2 years,8 months

F

IVa

anastomotic stenosis

22 years

abdominal pain

DB-ERC - > PTCD - > Surgery (lithotomy+strictureplasty)

improved

3

2 years, 6 months

F

IVa

right hepatic duct

21 years

abdominal pain

DB-ERC

stone recurrence

4

3 years,3 months

F

Ia

–

10 years

abdominal pain

DB-ERC

improved

5

2 years, 8 months

F

no dilatation

anastomotic stenosis

10 years

abdominal pain

DB-ERC

improved

6

1 year, 2 months

M

Ia

–

11 years

–

UDCA only

no change

7

1 year, 7 months

F

IVa

–

8 years

–

UDCA only

improved

8

1 year, 11 months

M

IVa

–

6 years

–

UDCA only

no change

9

5 months

F

Ia

–

7 years

–

UDCA only

improved

10

4 years, 5 months

F

IVa

–

3 years

–

UDCA only

no change

11

1 year, 11 months

F

IVa

–

11 years

abdominal pain

Surgery (lithotomy)

improved

12

5 months

M

IVa

lateral segmental branch

26 years

cholangitis abdominal pain

PTCD - > Surgery (hepatectomy)

died of cancer

  1. CBD congenital biliary dilatation; IHBD intrahepatic bile duct; DB-ERC double balloon endoscopic retrograde cholangiography; PTCD percutaneous transhepatic cholangio drainage; UDCA ursodeoxycholic acid